Interview with the Centre for Innovation in Healthcare (CIH) in Singapore
What is CIH?
What does CIH do?
As CIH partners with many experts within the healthtech ecosystem, we can effectively support our innovators to overcome challenges in various stages of the innovation process. We are also proud to have built a vibrant co-innovation community. Companies can leverage this network to accelerate the journey towards clinical and market adoption.
How does CIH support Clinical Adoption?
1) Usability Trial SessionsFor clinicians to provide innovators with clinical insights, CIH conducts usability sessions where relevant clinical users from NUHS institutions are invited to provide valuable feedback regarding the product and how it can be adopted into the clinical practice.
2) Clinical Validation & Health Technology Assessments (HTAs)After the successful matchmaking with a Clinical Principal Investigator (PI), CIH provides various clinical services that enable innovators to validate their innovation and assess their suitability for deployment within the NUHS cluster.
CIH will provide options for various services for clinical validation, these services include Domain Specific Review Board (DSRB) submission and Project Management of the clinical trial.
For start-ups looking at a systematic evaluation of the cost-effectiveness and impact of their health innovation, CIH has a network of health economists who can evaluate the health technology using established HTA methods, taking into account both clinical expert opinions and existing scientific evidence.
The evaluation would be able to provide evidence to guide decisions such as procurement, incorporation into clinical workflow, health policy decision, further development of the health technology.
A special place to collaborate and build links with Healthcare Innovation ecosystem partners
If companies want to do clinical validation at CIH, can they do it without disclosing their innovative secrets?
What is the usual cost and timeframe for clinical validation?
Any collaboration events with Japanese counterparts?
Any last thoughts or comments?
Please contact GPC if you are interested in communicating or collaborating with CIH.
Our consultants will help advise the best solutions regarding your healthcare innovations.